How to buy Intellia Therapeutics (NTLA) stock
Intellia Therapeutics (NASDAQ:NTLA) is a biotech company that focuses on gene editing, a relatively new technology that could allow scientists to devise therapies for otherwise impossible-to-treat conditions. As with any new technology, those who invest in it early enough could profit immensely in the long run. The question for investors, though, is whether Intellia is the best company to invest in to benefit from this potentially lucrative market.
How do I buy Intellia Therapeutics stock?
If you’d like to buy Intellia Therapeutics (NTLA) stock, you’ll need to find a broker or other intermediary that gives you the ability to purchase the stock through the NASDAQ stock market exchange. These intermediaries will be members of the exchange and use their access to buy and sell shares on your behalf.
You can open a brokerage account at a wide range of firms, from full-service brokers with a complete menu of financial services, to automated robo-advisors and online brokers. A full-service broker, while more expensive, provides expert investment research, advice, and commentary in addition to comprehensive financial planning. Those who want a set-it-and-forget-it approach to investing but don’t have the money or time to hire a full-service broker can opt for a roboadvisor. These are algorithmic investment platforms that you can manage through an app or website for a fraction of the cost of a traditional financial advisor. A discount broker is a cheaper option that provides basic execution services for investors who do their own research and analysis.
If all you want to do is buy stocks, an online brokerage is a better choice. Today, many online brokers offer commission-free trading along with free tools and screeners, making it easier than ever to trade stocks on your own. Several online brokerage platforms (such as Robinhood, Charles Schwab, Fidelity, Sofi and eToro) offer commission-free trading in most stocks and exchange-traded funds (ETFs).
The golden rule of investing is never to risk more than you can afford to lose. Buying NTLA stock is a rick investment and maybe will not alway result in a profit, so it is important to set a budget that not only allows good potential for capital growth, but also protects against overly damaging losses.
Investing or speculating in Intellia Therapeutics (NTLA) stock?
For an intelligent investor, money isn’t made simply by “following the market,” i.e., buying NTLA stock, because its value has gone up, or selling it because its value has waned. An excellent way to check if the market is swaying your value-judgments is to ask yourself whether you would be happy to invest in a NTLA stock if you were unable to know its market price. The only way to reach long-term investment goals is to make sustainable and reliable decisions that are not subject to the whims of the often volatile stock market.
Use Dollar-Cost Averaging to buy Intellia Therapeutics stock over time
You may have your eye on a stock, such as NTLA stock, that looks reasonably priced today, but who’s to say whether the price will be higher or lower tomorrow? Buy low and sell high can be psychologically challenging, and it can be very, very difficult even for experts to agree what “low” and “high” are for a given stock. Dollar-cost averaging allows you to get started buying stocks right away, with a little bit of money, rather than waiting to build your balance. This mitigates the risk you buy either extremely high or low since you’re spreading out your purchases across a long period of time.
Should you buy Intellia Therapeutics stock now?
According to data from Triangle Finance, Intellia Therapeutics has received a consensus rating of Buy, and is based on 19 buy ratings, 2 hold ratings, and no sell ratings. The 21 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 168.00, with a high estimate of 207.00 and a low estimate of 83.00. This rating has held steady since March, when it was unchanged from a buy rating.
